Reduced L-arginine transport contributes to the pathogenesis of myocardial ischemia-reperfusion injury

Journal of Cellular Biochemistry

Volumn 108, Issue 1, 2009, Pages 156-168

  Venardos, Kylie M ^a   Zatta, Amanda J ^a   Marshall, Tanneale ^a   Ritchie, Rebecca ^a   Kaye, David M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

L arginine; Myocardial ischemia reperfusion; Nitric oxide; Oxidative stress

Indexed keywords

3 NITROTYROSINE; AMINO ACID TRANSPORTER; ARGININE; NITRIC OXIDE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TROPONIN I;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; HEART CELL CULTURE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; ARGININE; MICE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NITRIC OXIDE; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TRPV CATION CHANNELS;

ADENOVIRIDAE; RATTUS;

EID: 69249154246     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22235     Document Type: Article

References (61)

1. Ambrosio G, Chiariello M. 1991. Myocardial reperfusion injury: Mechanisms and management - A review. Am J Med 91:86S-88S.
2. 2+ protects murine myocardium against ischemia-reperfusion dysfunction. Am J Physiol Heart Circ Physiol 289:H2183-H2192.
3. Baydoun AR, Wileman SM, Wheeler-Jones CP, Marber MS, Mann GE, Pearson JD, Closs EI. 1999. Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem J 344: Pt 1: 265-272.
4. Bijur GN, Jope RS. 2003. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 87:1427-1435.
5. Cadenas E, Davies KJ. 2000. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222-230.
6. Chin-Dusting JP, Willems L, Kaye DM. 2007. l-Arginine transporters in cardiovascular disease: A novel therapeutic target. Pharmacol Ther 116:428-436.
7. Cittadini A, Monti MG, Iaccarino G, Di Rella F, Tsichlis PN, Di Gianni A, Stromer H, Sorriento D, Peschle C, Trimarco B, Sacca L, Condorelli G. 2006. Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. Gene Ther 13:8-19.
8. Depre C, Fierain L, Hue L. 1997. Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res 33:82-87.
9. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman RM, Rousou JA, Flack JE III, Deaton DW, Das DK. 1995. L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg 60:1275-1281.
10. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T, Cargnoni A, Ceconi C, Curello S, Visioli O. 1998a. Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J 19 Suppl B: B2-B11.
11. Ferrari R, Pepi P, Ferrari F, Nesta F, Benigno M, Visioli O. 1998b. Metabolic derangement in ischemic heart disease and its therapeutic control. Am J Cardiol 82:2K-13K.
12. Flood AJ, Willems L, Headrick JP. 2002. Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart. Cardiovasc Res 55:161-170.
13. Forman MB, Virmani R, Puett DW. 1990. Mechanisms and therapy of myocardial reperfusion injury. Circulation 81(I): V69-V78.
14. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. 2000. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101:660-667.
15. Gao WD, Atar D, Backx PH, Marban E. 1995. Relationship between intracellular calcium and contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76:1036-1048.
16. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. 1997. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80:393-399.
17. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, Chilian WM, Zhang C. 2007. TNF-{alpha} contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 27:1269-1275.
18. Giraldez RR, Panda A, Xia Y, Sanders SP, Zweier JL. 1997. Decreased nitricoxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J Biol Chem 272:21420-21426.
19. Gold ME, Bush PA, Ignarro LJ. 1989. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun 164:714-721.
20. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM. 1994. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267:H1804-H1813.
21. Gryglewski RJ, Palmer RM, Moncada S. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456.
22. Hausenloy DJ, Yellon DM. 2007. Reperfusion injury salvage kinase signalling: Taking a RISK for cardioprotection. Heart Fail Rev 12:217-234.
23. Headrick JP, Peart J, Hack B, Flood A, Matherne GP. 2001. Functional properties and responses to ischaemia-reperfusion in Langendorff perfused mouse heart. Exp Physiol 86:703-716.
24. Hearse DJ, Tosaki A. 1987. Free radicals and reperfusion-induced arrhythmias: Protection by spin trap agent PBN in the rat heart. Circ Res 60:375-383.
25. 2+-pump activity by oxygen free radicals. Am J Physiol 256:H368-H374.
26. Kaye DM, Ahlers BA, Autelitano DJ, Chin-Dusting JP. 2000. In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation 102:2707-2712.
27. Kloner RA, Przyklenk K, Whittaker P. 1989. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 80:1115-1127.
28. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, Kaye DM, Ritchie RH. 2006. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72:112-123.
29. Lass A, Suessenbacher A, Wolkart G, Mayer B, Brunner F. 2002. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol Pharmacol 61:1081-1088.
30. Loke KE, Forfia PR, Recchia FA, Xu X, Osorio JC, Ochoa M, Gawryl M, Hintze TH. 2000. Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: Role of nitric oxide. J Cardiovasc Pharmacol 35:84-92.
31. Lucchesi BR. 1990. Myocardial ischemia, reperfusion and free radical injury. Am J Cardiol 65:14I-23I.
32. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. 2003. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201.
33. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A. 2001. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330-335.
34. McDonald KK, Zharikov S, Block ER, Kilberg MS. 1997. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272:31213-31216.
35. McDonough JL, Arrell DK, Van Eyk JE. 1999. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 84:9-20.
36. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC III, McGee DS, Johnston WE. 1992. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263:H1650-H1658.
37. Nonami Y, Rao V, Shiono N, Ogoshi S. 1998. Quenching the effects of L-arginine on free radical injury in cultured cardiomyocytes. Surg Today 28:379-384.
38. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. 2004. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37:449-471.
39. Prasan AM, McCarron HC, Zhang Y, Jeremy RW. 2007. Myocardial release of nitric oxide during ischaemia and reperfusion: Effects of L-arginine and hypercholesterolaemia. Heart Lung Circ 16:274-281.
40. Rezkalla SH, Kloner RA. 2002. No-reflow phenomenon. Circulation 105:656-662.
41. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. 2002. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34:379-388.
42. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang WZ, Kaye DM. 2004. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 110:3680-3686.
43. Schneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L, Gambaryan S, Wanner C, Schmidt HH, Galle J. 2003. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 64:216-225.
44. Shah AM, Lewis MJ. 1992. Endothelial modulation of myocardial contraction: Mechanisms and potential relevance in cardiac disease. Basic Res Cardiol 87(Suppl 2): 59-70.
45. Shah AM, Grocott-Mason RM, Pepper CB, Mebazaa A, Henderson AH, Lewis MJ, Paulus WJ. 1996. The cardiac endothelium: Cardioactive mediators. Prog Cardiovasc Dis 39:263-284.
46. Solaro RJ, Van Eyk J. 1996. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 28:217-230.
47. Suessenbacher A, Lass A, Mayer B, Brunner F. 2002. Antioxidative and myocardial protective effects of L-arginine in oxygen radical-induced injury of isolated perfused rat hearts. Naunyn Schmiedebergs Arch Pharmacol 365:269-276.
48. Takeuchi K, McGowan FX, Danh HC, Glynn P, Simplaceanu E, del Nido PJ. 1995. Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol 27:1405-1414.
49. Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ. 1998. Breakdown and release of myofilament proteins during ischemia and ischemia/ reperfusion in rat hearts: Identification of degradation products and effects on the pCa-force relation. Circ Res 82:261-271.
50. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA, Jr. 1998. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA 95:9220-9225.
51. Venardos KM, Kaye DM. 2007. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: A review. Curr Med Chem 14:1539-1549.
52. Wang QD, Morcos E, Wiklund P, Pernow J. 1997. L-arginine enhances functional recovery and Ca(2+)-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol 29:291-296.
53. Wascher TC, Posch K, Wallner S, Hermetter A, Kostner GM, Graier WF. 1997. Vascular effects of L-arginine: Anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commun 234:35-38.
54. Westfall MV, Solaro RJ. 1992. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res 70:302-313.
55. Weyrich AS, Ma XL, Lefer AM. 1992. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86:279-288.
56. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. 1996. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93:6770-6774.
57. Yamashita K, Kajstura J, Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, Webster KA. 2001. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 88:609-614.
58. Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye DM. 2007. Identification of a novel polymorphism in the 3′UTR of the L-arginine transporter gene SLC7 A1: Contribution to hypertension and endothelial dysfunction. Circulation 115:1269-1274.
59. Yellon DM, Downey JM. 2003. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 83:1113-1151.
60. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. 2006. Adverse effects of cigarette smoke on NO bioavailability: Role of arginine metabolism and oxidative stress. Hypertension 48:278-285.
61. Zharikov SI, Block ER. 2000. Association of L-arginine transporters with fodrin: Implications for hypoxic inhibition of arginine uptake. Am J Physiol Lung Cell Mol Physiol 278:L111-L117.